India, July 1 -- Vivos Therapeutics Stock Gains 12% After It Receives Medicare Approval for VidaSleep Oral Appliance
Shares of Vivos Therapeutics, Inc. (VVOS) is currently gaining over 12% on Tuesday morning after the medical technology company received medicare approval for VidaSleep oral appliance.
VVOS is currently trading at $3.5654, up $0.4054 or 12.8291%, on a large volume of 19.2 million, above average volume of 147 thousand, on the Nasdaq. The stock opened at $4.2200 after closing Monday at $3.1600. The stock has traded between $1.9700 and $6.2800 in the past 52-week period.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Vivos Therapeutics announced that its VidaSleep oral appliance, featuri...